BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32313136)

  • 1. RNA Sequence Analyses throughout the Course of Mouse Cardiac Laminopathy Identify Differentially Expressed Genes for Cell Cycle Control and Mitochondrial Function.
    Shao Z; Koh W; Ni Y; Li W; Agatisa-Boyle B; Merkurjev D; Tang WHW
    Sci Rep; 2020 Apr; 10(1):6632. PubMed ID: 32313136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.
    Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G
    Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice.
    Auguste G; Rouhi L; Matkovich SJ; Coarfa C; Robertson MJ; Czernuszewicz G; Gurha P; Marian AJ
    J Clin Invest; 2020 Sep; 130(9):4740-4758. PubMed ID: 32484798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
    Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
    Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alpha-helix variant p.Arg156Pro in LMNA as a cause of hereditary dilated cardiomyopathy: genetics and bioinfomatics exploration.
    Chang L; Huang R; Chen J; Li G; Shi G; Xu B; Wang L
    BMC Med Genomics; 2023 Oct; 16(1):229. PubMed ID: 37784143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesprin-1 and actin contribute to nuclear and cytoskeletal defects in lamin A/C-deficient cardiomyopathy.
    Nikolova-Krstevski V; Leimena C; Xiao XH; Kesteven S; Tan JC; Yeo LS; Yu ZY; Zhang Q; Carlton A; Head S; Shanahan C; Feneley MP; Fatkin D
    J Mol Cell Cardiol; 2011 Mar; 50(3):479-86. PubMed ID: 21156181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in lamin A/C sensitizes the myocardium to exercise-induced mechanical stress but has no effect on skeletal muscles in mouse.
    Cattin ME; Ferry A; Vignaud A; Mougenot N; Jacquet A; Wahbi K; Bertrand AT; Bonne G
    Neuromuscul Disord; 2016 Aug; 26(8):490-9. PubMed ID: 27287550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
    Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
    J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation.
    Chatzifrangkeskou M; Yadin D; Marais T; Chardonnet S; Cohen-Tannoudji M; Mougenot N; Schmitt A; Crasto S; Di Pasquale E; Macquart C; Tanguy Y; Jebeniani I; Pucéat M; Morales Rodriguez B; Goldmann WH; Dal Ferro M; Biferi MG; Knaus P; Bonne G; Worman HJ; Muchir A
    Hum Mol Genet; 2018 Sep; 27(17):3060-3078. PubMed ID: 29878125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal p38α mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation.
    Muchir A; Wu W; Choi JC; Iwata S; Morrow J; Homma S; Worman HJ
    Hum Mol Genet; 2012 Oct; 21(19):4325-33. PubMed ID: 22773734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A-type lamins gene.
    Rodriguez BM; Khouzami L; Decostre V; Varnous S; Pekovic-Vaughan V; Hutchison CJ; Pecker F; Bonne G; Muchir A
    Hum Mol Genet; 2018 Oct; 27(19):3353-3360. PubMed ID: 29982513
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kato K; Ohno S; Sonoda K; Fukuyama M; Makiyama T; Ozawa T; Horie M
    Circ Genom Precis Med; 2020 Oct; 13(5):435-443. PubMed ID: 32818388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LMNA E82K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice.
    Lu D; Lian H; Zhang X; Shao H; Huang L; Qin C; Zhang L
    PLoS One; 2010 Dec; 5(12):e15167. PubMed ID: 21151901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.
    Jia Y; Chang HC; Schipma MJ; Liu J; Shete V; Liu N; Sato T; Thorp EB; Barger PM; Zhu YJ; Viswakarma N; Kanwar YS; Ardehali H; Thimmapaya B; Reddy JK
    PLoS One; 2016; 11(8):e0160755. PubMed ID: 27548259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.